- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
The mean (CV) Cmax value was 3831 (40%) pg/mL and the median Tmax was 0.15 h
Studies by Seiwerth et al
Specifications: 3 ply disposable Beauty Sheet: 2 ply paper bonded to a layer of plastic
BPC-157s angiogenesis promotion becomes especially valuable for TFCC injuries where new blood vessel formation may be the limiting factor in recovery
However, long-term human studies on BPC-157 peptide therapy are still limited, and more research is needed to confirm its full safety profile